Cargando...
Optimizing the Use of Neoadjuvant Endocrine Therapy
Nowadays, neoadjuvant endocrine therapy is a clinically acceptable (and sometimes preferred) strategy in patients with operable estrogen receptor-positive (ER+) breast cancer. Despite the overall effectiveness of endocrine therapy in breast cancer in all settings, de novo (primary) and acquired (sec...
Gardado en:
| Publicado en: | Curr Oncol Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5524371/ https://ncbi.nlm.nih.gov/pubmed/26008918 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11912-015-0455-z |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|